Pharmaceutical Market Access Act of 2003
Latest action · Jul 25, 2003 Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedJun 11, 2003
- Passed HouseJul 25, 2003
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
(This measure has not been amended since it was introduced. The summary has been expanded because action occurred on the measure.)
Pharmaceutical Market Access Act of 2003 - (Sec. 4) Amends the Federal Food, Drug and Cosmetic Act to direct the Secretary of Health and Human Services to promulgate regulations allowing qualifying individuals to import covered products (in addition to pharmacists and wholesalers, whom current law authorizes to import such products).
Amends provision pertaining to record keeping regarding imported covered products. States that the Secretary shall not have to store records in cases in which qualifying individuals have imported a covered product.
Amends provisions regarding the importation of covered products, including to remove language directing the Secretary to require that a foreign seller specify the original source of the product and the amount of each lot of the product originally received.
Amends provisions regarding the testing of imported covered products. Declares that specified tests, including ones involving authenticity and degradation of products, shall not be required unless the importer is a wholesaler. Requires such tests to be conducted by the importer unless a product is a prescription drug subject to the provisions of this Act pertaining to counterfeit-resistant packaging. (Currently either the importer or the manufacturer may conduct such tests).
Eliminates the sunset date current law establishes for the provisions pertaining to the importation of covered products.
(Sec. 5) Classifies prescription drugs as misbranded if they do not incorporate specified counterfeit-resistant technologies in packaging.
Recorded votes 1
Newest first. Open one to see how every member voted.
| Roll call | Question | Result | Date |
|---|---|---|---|
| House 445 | On Passage | Passed243–186 | Jul 25, 2003 |
Cosponsors 53
Members who signed on, in the order they did. Signatures ran from Jun 11, 2003 to Jul 23, 2003; 26 are original cosponsors, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-KY | Anne M. Northup | Original | Jun 11, 2003 |
| D-MA | Barney Frank | Original | Jun 11, 2003 |
| R-NC | Charles H. Taylor | Original | Jun 11, 2003 |
| R-CT | Christopher Shays | Original | Jun 11, 2003 |
| D-MN | Collin C. Peterson | Original | Jun 11, 2003 |
| R-IN | Dan Burton | Original | Jun 11, 2003 |
| R-CA | Dana Rohrabacher | Original | Jun 11, 2003 |
| R-MT | Denny Rehberg | Original | Jun 11, 2003 |
| R-NE | Doug Bereuter | Original | Jun 11, 2003 |
| R-OK | Ernest J. Istook Jr. | Original | Jun 11, 2003 |
| R-SC | Henry E. Brown, Jr. | Original | Jun 11, 2003 |
| R-GA | Jack Kingston | Original | Jun 11, 2003 |
| R-TX | Jeb Hensarling | Original | Jun 11, 2003 |
| R-MN | Jim Ramstad | Original | Jun 11, 2003 |
| R-MO | Jo Ann Emerson | Original | Jun 11, 2003 |
Committees 2
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Jun 11, 2003 |
| Health Subcommittee | Referred Jun 24, 2003 | |
| Senate | Health, Education, Labor, and Pensions Committee | Referred Jul 25, 2003 |
Actions 15
Everything that happened, newest first.
- Jul 25, 2003Considered under the provisions of rule H. Res. 335. (consideration: CR H7595-7611)
- Jul 25, 2003Rule provides for consideration of H.R. 2427.
- Jul 25, 2003DEBATE - The House proceeded with one hour of debate on H.R. 2427.
- Jul 25, 2003The previous question was ordered pursuant to the rule.
- Jul 25, 2003Mr. Dingell moved to recommit to Energy and Commerce. (consideration: CR H7610; text: CR H7595-7596)
- Jul 25, 2003The previous question on the motion to recommit was ordered without objection.
- Jul 25, 2003On motion to recommit Failed by voice vote.
- Jul 25, 2003Passed/agreed to in House: On passage Passed by recorded vote: 243 - 186 (Roll no. 445).
- Jul 25, 2003Motion to reconsider laid on the table Agreed to without objection.
- Jul 25, 2003Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Jul 24, 2003Rules Committee Resolution H. Res. 335 Reported to House. Rule provides for consideration of H.R. 2427.
- Jul 24, 2003Rule H. Res. 335 passed House.
- Jun 24, 2003Referred to the Subcommittee on Health.
- Jun 11, 2003Introduced in House
- Jun 11, 2003Referred to the House Committee on Energy and Commerce.
In the Congressional Record 13
Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.
| Where | In the Record | Members | Date |
|---|---|---|---|
| House | Debate and remarks H5168 | Rahm Emanuel D-IL | Jul 6, 2004 |
| House | Debate and remarks H9465Advertisements H9466 | Gil Gutknecht R-MN | Oct 15, 2003 |
| House | Debate and remarks H8261 | Rahm Emanuel D-IL | Sep 16, 2003 |
| House | Debate and remarks H7813 | Rahm Emanuel D-IL | Sep 3, 2003 |
| Extensions | Debate and remarks E1617, E1621, E1622, E1642, E1647, E1648, E1658, E1659 | Bart Stupak D-MI, Bob Etheridge D-NC, Carolyn B. Maloney D-NY, Carolyn McCarthy D-NY, James A. Leach R-IA, Jerry F. Costello D-IL, Nick Smith R-MI, Walter B. Jones R-NC | Jul 25, 2003 |
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Congressional Budget Office cost estimates 2
- Nov 19, 2003H.R. 2427, Pharmaceutical Market Access Act of 2003<p>Cost estimate for the bill as passed by the U.S. House of Representatives on July 25, 2003</p>
- Nov 19, 2003H.R. 2427, Pharmaceutical Market Access Act of 2003Cost estimate for the bill as passed by the U.S. House of Representatives on July 25, 2003
Printed hearings 3
Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.
| Number | Hearing | Committee | Held |
|---|---|---|---|
| S. Hrg. 108-923 | EXAMINING THE IMPLICATIONS OF DRUG IMPORTATION282 pages | Judiciary Committee | Jul 14, 2004 |
| S. Hrg. 108-470 | IMPORTATION OF PRESCRIPTION DRUGS129 pages | Health, Education, Labor, and Pensions Committee | May 20, 2004 |
| S. Hrg. 108-1011 | PRESCRIPTION DRUG REIMPORTATION123 pages | Commerce, Science, and Transportation Committee | Nov 20, 2003 |
CRS reports 1
Congressional Research Service work that CRS links to this bill or the law it became, newest first.
Cite it 1
Products on other subjects that cite it, usually among other measures.
| Product | Title | Kind | Published |
|---|---|---|---|
| RS22660 | Prescription Drug Importation: How S. 1232 (S. 525/H.R. 1298) Would Change Current Law Archived | Report | Jun 16, 2009 |
Related bills 3
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| HRES 335 | Providing for consideration of the bill (H.R. 2427) to authorize the Secretary of Health and Human Services to promulgate regulations for the reimportation of prescription drugs, and for other purposes. | Procedurally related | Jul 24, 2003 |
| S 1781 | Pharmaceutical Market Access Act of 2003 | Related bill | Oct 24, 2003 |
| S 2137 | Pharmaceutical Market Access Act of 2003 | Related bill | Sep 8, 2004 |
Titles 4
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To authorize the Secretary of Health and Human Services to promulgate regulations for the reimportation of prescription drugs, and for other purposes.
- Short Titles as Introduced
- Pharmaceutical Market Access Act of 2003
- Short Titles as Passed House
- Pharmaceutical Market Access Act of 2003
- Popular Titles
- Imports of Prescription Drugs bill
Subjects
Assigned by the Library of Congress. Policy area: Health.
- Administrative procedure
- Commerce
- Congress
- Congressional reporting requirements
- Consumer protection
- Counterfeiting
- Crime and Law Enforcement
- Department of Health and Human Services
- Drug industry
- Drugs
- Foreign Trade and International Finance
- Government Operations and Politics
- Government paperwork
- Governmental investigations
- Health
- Identification devices
- Import restrictions
- Imports
- Labeling
- Law
- Packaging
- Prescription pricing
- Product safety
- Science, Technology, Communications
- Sunset legislation
Text 3
Each version as it was printed, newest first.
- Jul 25, 2003Referred in Senate
- Jul 25, 2003Engrossed in House
- Jun 11, 2003Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.